Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Macrophage Colony-Stimulating Factor | 24 | 2014 | 186 | 4.090 |
Why?
|
Lupus Nephritis | 25 | 2019 | 318 | 3.840 |
Why?
|
Kidney Tubules | 23 | 2019 | 449 | 1.810 |
Why?
|
Mice, Inbred MRL lpr | 21 | 2019 | 153 | 1.570 |
Why?
|
Macrophages | 25 | 2019 | 5737 | 1.460 |
Why?
|
Interleukins | 3 | 2022 | 783 | 1.380 |
Why?
|
Nephritis | 9 | 2008 | 147 | 1.260 |
Why?
|
Kidney | 25 | 2012 | 7016 | 1.120 |
Why?
|
Autoimmune Diseases | 20 | 2008 | 2244 | 1.020 |
Why?
|
Receptor-Like Protein Tyrosine Phosphatases, Class 5 | 1 | 2022 | 18 | 0.820 |
Why?
|
Mice, Inbred C3H | 18 | 2009 | 915 | 0.720 |
Why?
|
Gene Transfer Techniques | 10 | 2010 | 1203 | 0.710 |
Why?
|
Arthritis, Experimental | 1 | 2022 | 291 | 0.680 |
Why?
|
Kidney Glomerulus | 12 | 2014 | 568 | 0.640 |
Why?
|
Monocytes | 4 | 2019 | 2570 | 0.630 |
Why?
|
Cell Death | 3 | 2019 | 1667 | 0.560 |
Why?
|
Muscular Dystrophies, Limb-Girdle | 1 | 2017 | 62 | 0.550 |
Why?
|
T-Lymphocytes | 17 | 2007 | 10171 | 0.500 |
Why?
|
Interferon-gamma | 10 | 2010 | 3156 | 0.480 |
Why?
|
Primary Graft Dysfunction | 1 | 2015 | 111 | 0.460 |
Why?
|
Kidney Diseases | 7 | 2007 | 2083 | 0.450 |
Why?
|
Membrane Glycoproteins | 5 | 2008 | 3705 | 0.420 |
Why?
|
Mice | 60 | 2022 | 81107 | 0.410 |
Why?
|
Cell Survival | 4 | 2019 | 5781 | 0.370 |
Why?
|
Chemokine CCL2 | 4 | 2003 | 604 | 0.360 |
Why?
|
Chemokines | 4 | 2019 | 961 | 0.350 |
Why?
|
Macrophage Activation | 4 | 2011 | 552 | 0.350 |
Why?
|
Mice, Knockout | 15 | 2022 | 14354 | 0.350 |
Why?
|
Kidney Transplantation | 7 | 2015 | 4217 | 0.340 |
Why?
|
Interleukin-12 | 3 | 2010 | 583 | 0.340 |
Why?
|
Animals | 69 | 2022 | 167777 | 0.330 |
Why?
|
Epithelial Cells | 13 | 2015 | 3665 | 0.330 |
Why?
|
Molecular Targeted Therapy | 2 | 2019 | 2796 | 0.330 |
Why?
|
Tumor Necrosis Factor-alpha | 9 | 2005 | 4342 | 0.320 |
Why?
|
Receptor, Macrophage Colony-Stimulating Factor | 3 | 2015 | 94 | 0.300 |
Why?
|
Mice, Inbred C57BL | 17 | 2019 | 22006 | 0.300 |
Why?
|
Chemokine CXCL9 | 1 | 2008 | 135 | 0.300 |
Why?
|
Apoptosis | 10 | 2011 | 9468 | 0.300 |
Why?
|
Lupus Erythematosus, Systemic | 5 | 2008 | 2159 | 0.290 |
Why?
|
Mice, Transgenic | 9 | 2017 | 9518 | 0.290 |
Why?
|
Ureteral Obstruction | 2 | 2006 | 292 | 0.280 |
Why?
|
Receptors, CXCR3 | 1 | 2008 | 238 | 0.280 |
Why?
|
Down-Regulation | 6 | 2007 | 2905 | 0.280 |
Why?
|
Reperfusion Injury | 3 | 2012 | 1022 | 0.280 |
Why?
|
Sunlight | 1 | 2008 | 337 | 0.280 |
Why?
|
Chemokine CXCL10 | 1 | 2008 | 316 | 0.280 |
Why?
|
Arthritis, Rheumatoid | 1 | 2022 | 3755 | 0.270 |
Why?
|
Granulocyte-Macrophage Colony-Stimulating Factor | 6 | 2003 | 886 | 0.260 |
Why?
|
Peptides | 2 | 2008 | 4341 | 0.260 |
Why?
|
Mice, Inbred BALB C | 11 | 2012 | 6209 | 0.250 |
Why?
|
Cell Communication | 2 | 2017 | 1651 | 0.250 |
Why?
|
Mice, Mutant Strains | 11 | 2005 | 1751 | 0.240 |
Why?
|
Antigens, Surface | 1 | 2008 | 1607 | 0.230 |
Why?
|
Autoantibodies | 2 | 2005 | 2118 | 0.230 |
Why?
|
Interleukin-15 | 2 | 2002 | 183 | 0.230 |
Why?
|
Cell Proliferation | 6 | 2019 | 10417 | 0.220 |
Why?
|
Antigens, Differentiation, T-Lymphocyte | 1 | 2005 | 899 | 0.220 |
Why?
|
Nephritis, Interstitial | 2 | 2002 | 154 | 0.220 |
Why?
|
Apoptosis Regulatory Proteins | 1 | 2008 | 1134 | 0.210 |
Why?
|
Acute Kidney Injury | 1 | 2015 | 1926 | 0.210 |
Why?
|
Disease Progression | 4 | 2019 | 13468 | 0.210 |
Why?
|
Muscle, Skeletal | 1 | 2017 | 4902 | 0.200 |
Why?
|
Cell Count | 3 | 2017 | 1835 | 0.200 |
Why?
|
Cells, Cultured | 10 | 2019 | 18942 | 0.190 |
Why?
|
Severity of Illness Index | 3 | 2017 | 15785 | 0.190 |
Why?
|
Renal Insufficiency, Chronic | 1 | 2015 | 2239 | 0.190 |
Why?
|
Cytokines | 8 | 2004 | 7338 | 0.180 |
Why?
|
Myocarditis | 1 | 2008 | 766 | 0.180 |
Why?
|
Lymphocyte Activation | 7 | 2000 | 5490 | 0.180 |
Why?
|
Interleukin-18 | 3 | 2010 | 250 | 0.170 |
Why?
|
Receptors, Interleukin-2 | 6 | 2002 | 562 | 0.170 |
Why?
|
Epithelium | 7 | 2004 | 1605 | 0.170 |
Why?
|
Skin Diseases | 1 | 2008 | 1088 | 0.170 |
Why?
|
Synovial Membrane | 1 | 2022 | 524 | 0.160 |
Why?
|
Immunoglobulin Isotypes | 3 | 2004 | 158 | 0.160 |
Why?
|
Cell Division | 9 | 2005 | 4459 | 0.160 |
Why?
|
Proteinuria | 5 | 2005 | 594 | 0.160 |
Why?
|
Histocompatibility Antigens Class II | 5 | 1994 | 1446 | 0.150 |
Why?
|
Species Specificity | 2 | 2019 | 2417 | 0.150 |
Why?
|
Chemokine CCL5 | 1 | 1998 | 215 | 0.150 |
Why?
|
Glomerular Mesangium | 2 | 1998 | 98 | 0.140 |
Why?
|
Cell Movement | 4 | 2003 | 5201 | 0.140 |
Why?
|
Kidney Tubules, Proximal | 2 | 2001 | 382 | 0.140 |
Why?
|
Pneumonia | 1 | 2008 | 2129 | 0.140 |
Why?
|
Lymphatic Diseases | 3 | 2004 | 319 | 0.130 |
Why?
|
Carcinoma, Renal Cell | 1 | 2011 | 3217 | 0.130 |
Why?
|
Interleukin-4 | 4 | 2005 | 1130 | 0.130 |
Why?
|
Antigens, CD | 3 | 2007 | 3997 | 0.130 |
Why?
|
Corn Oil | 1 | 1995 | 28 | 0.130 |
Why?
|
Kidney Neoplasms | 1 | 2011 | 4312 | 0.120 |
Why?
|
Growth Substances | 1 | 1997 | 768 | 0.120 |
Why?
|
DNA Primers | 3 | 2011 | 2816 | 0.120 |
Why?
|
Protein Isoforms | 2 | 2011 | 1694 | 0.120 |
Why?
|
Interleukin-10 | 2 | 2005 | 1174 | 0.110 |
Why?
|
Muscle Fibers, Skeletal | 1 | 2017 | 540 | 0.110 |
Why?
|
Clonal Anergy | 1 | 1994 | 171 | 0.110 |
Why?
|
Graft Rejection | 8 | 1999 | 4426 | 0.110 |
Why?
|
Leukopenia | 2 | 2004 | 211 | 0.110 |
Why?
|
Genetic Engineering | 1 | 1999 | 933 | 0.110 |
Why?
|
Disease Models, Animal | 7 | 2019 | 18125 | 0.110 |
Why?
|
Necrosis | 1 | 2017 | 1604 | 0.100 |
Why?
|
Inflammation | 4 | 2022 | 10719 | 0.100 |
Why?
|
Salivary Glands | 2 | 2004 | 229 | 0.100 |
Why?
|
Phenotype | 4 | 2017 | 16534 | 0.100 |
Why?
|
Alprostadil | 1 | 1992 | 86 | 0.100 |
Why?
|
Complement C3 | 2 | 2004 | 451 | 0.100 |
Why?
|
Muromonab-CD3 | 1 | 1992 | 104 | 0.100 |
Why?
|
Lacrimal Apparatus | 2 | 2004 | 223 | 0.100 |
Why?
|
Drug Delivery Systems | 1 | 2003 | 2211 | 0.100 |
Why?
|
Flow Cytometry | 3 | 2008 | 5864 | 0.100 |
Why?
|
Splenomegaly | 2 | 2004 | 189 | 0.090 |
Why?
|
Radiation Chimera | 2 | 2008 | 216 | 0.090 |
Why?
|
B-Lymphocytes | 1 | 2004 | 4738 | 0.090 |
Why?
|
Transforming Growth Factor beta | 2 | 1996 | 1957 | 0.090 |
Why?
|
Up-Regulation | 4 | 2006 | 4114 | 0.090 |
Why?
|
STAT4 Transcription Factor | 1 | 2010 | 93 | 0.090 |
Why?
|
Transfection | 3 | 2001 | 5779 | 0.090 |
Why?
|
Antigen Presentation | 2 | 1994 | 1254 | 0.090 |
Why?
|
Mice, Inbred NOD | 2 | 1992 | 1825 | 0.090 |
Why?
|
Adjuvants, Immunologic | 1 | 1996 | 1038 | 0.090 |
Why?
|
Antigens, Ly | 1 | 2011 | 292 | 0.090 |
Why?
|
Base Sequence | 5 | 2011 | 12436 | 0.090 |
Why?
|
Interleukin-6 | 2 | 1997 | 3208 | 0.080 |
Why?
|
Interleukin-2 | 6 | 1993 | 1888 | 0.080 |
Why?
|
Spleen | 4 | 2004 | 2296 | 0.080 |
Why?
|
Lymphokines | 1 | 1992 | 926 | 0.080 |
Why?
|
Immunoglobulin G | 4 | 2005 | 4540 | 0.080 |
Why?
|
Carrier Proteins | 1 | 2022 | 4937 | 0.080 |
Why?
|
Gene Expression Regulation | 4 | 2019 | 11894 | 0.080 |
Why?
|
Cyclosporins | 1 | 1988 | 216 | 0.080 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 3 | 2007 | 4567 | 0.080 |
Why?
|
Moloney murine leukemia virus | 2 | 1999 | 109 | 0.080 |
Why?
|
Antigen-Presenting Cells | 4 | 1994 | 964 | 0.080 |
Why?
|
Fish Oils | 1 | 1992 | 481 | 0.080 |
Why?
|
Immune Sera | 2 | 2007 | 613 | 0.080 |
Why?
|
Lipopolysaccharides | 1 | 1996 | 2204 | 0.080 |
Why?
|
Cytoplasm | 1 | 1992 | 1514 | 0.080 |
Why?
|
Receptors, Interferon | 2 | 1998 | 116 | 0.080 |
Why?
|
Signal Transduction | 4 | 2011 | 23341 | 0.070 |
Why?
|
Prostaglandins | 1 | 1988 | 398 | 0.070 |
Why?
|
Immune Tolerance | 2 | 1995 | 2297 | 0.070 |
Why?
|
Recombinant Fusion Proteins | 5 | 1998 | 3734 | 0.070 |
Why?
|
Cell Adhesion Molecules | 4 | 1993 | 1600 | 0.070 |
Why?
|
Female | 20 | 2015 | 390316 | 0.070 |
Why?
|
Gene Expression | 3 | 2008 | 7583 | 0.070 |
Why?
|
Islets of Langerhans | 1 | 1992 | 1345 | 0.070 |
Why?
|
Adoptive Transfer | 1 | 2008 | 819 | 0.070 |
Why?
|
Mice, Inbred CBA | 1 | 2006 | 436 | 0.060 |
Why?
|
RNA, Messenger | 5 | 2007 | 12760 | 0.060 |
Why?
|
Blood Urea Nitrogen | 1 | 2005 | 186 | 0.060 |
Why?
|
Clone Cells | 3 | 1993 | 1660 | 0.060 |
Why?
|
Fatty Acids, Omega-3 | 1 | 1995 | 1373 | 0.060 |
Why?
|
Immunosuppressive Agents | 3 | 1995 | 4158 | 0.060 |
Why?
|
Receptors, Interleukin-15 | 2 | 2002 | 13 | 0.060 |
Why?
|
Bone Marrow | 3 | 2004 | 2909 | 0.060 |
Why?
|
Dexamethasone | 1 | 1992 | 1927 | 0.060 |
Why?
|
Cell Migration Inhibition | 1 | 2004 | 97 | 0.060 |
Why?
|
Mice, Inbred Strains | 3 | 1998 | 1759 | 0.060 |
Why?
|
Intercellular Adhesion Molecule-1 | 3 | 1993 | 1125 | 0.060 |
Why?
|
Keratinocytes | 1 | 2008 | 790 | 0.060 |
Why?
|
Genetic Vectors | 3 | 1999 | 3380 | 0.060 |
Why?
|
Leukocytes | 2 | 2004 | 2025 | 0.060 |
Why?
|
T-Lymphocyte Subsets | 1 | 1992 | 1807 | 0.060 |
Why?
|
Fluorescent Antibody Technique | 1 | 2008 | 2470 | 0.060 |
Why?
|
Cell Transplantation | 2 | 1996 | 472 | 0.060 |
Why?
|
Immunotoxins | 3 | 1994 | 175 | 0.060 |
Why?
|
Dietary Fats | 1 | 1992 | 1991 | 0.060 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 2 | 2008 | 3801 | 0.060 |
Why?
|
IgG Deficiency | 1 | 2003 | 29 | 0.050 |
Why?
|
Immunophenotyping | 1 | 2008 | 1871 | 0.050 |
Why?
|
Growth Inhibitors | 1 | 2004 | 378 | 0.050 |
Why?
|
Proteoglycans | 1 | 2006 | 801 | 0.050 |
Why?
|
Diphtheria Toxin | 3 | 1993 | 252 | 0.050 |
Why?
|
Bone Marrow Transplantation | 2 | 2008 | 2693 | 0.050 |
Why?
|
RNA Interference | 1 | 2011 | 2836 | 0.050 |
Why?
|
Regeneration | 2 | 2009 | 1505 | 0.050 |
Why?
|
Homeostasis | 1 | 1993 | 3302 | 0.050 |
Why?
|
Immunohistochemistry | 3 | 2008 | 11070 | 0.050 |
Why?
|
Biopsy | 1 | 2014 | 6768 | 0.050 |
Why?
|
Fibrosis | 1 | 2009 | 2038 | 0.050 |
Why?
|
Kidney Pelvis | 1 | 2003 | 188 | 0.050 |
Why?
|
Skin | 3 | 2005 | 4464 | 0.050 |
Why?
|
Dactinomycin | 1 | 2002 | 304 | 0.050 |
Why?
|
Recombinant Proteins | 4 | 2005 | 6520 | 0.050 |
Why?
|
Interferon Type I | 1 | 2005 | 559 | 0.050 |
Why?
|
Lymphopenia | 1 | 2003 | 280 | 0.050 |
Why?
|
Hypersensitivity, Delayed | 3 | 1998 | 490 | 0.040 |
Why?
|
Antibodies, Monoclonal | 6 | 1994 | 9160 | 0.040 |
Why?
|
Membrane Proteins | 1 | 2017 | 7843 | 0.040 |
Why?
|
Lung | 3 | 2004 | 9985 | 0.040 |
Why?
|
Sheep | 1 | 2002 | 1441 | 0.040 |
Why?
|
Mice, Congenic | 1 | 1999 | 97 | 0.040 |
Why?
|
Male | 12 | 2014 | 358742 | 0.040 |
Why?
|
Antibodies, Antinuclear | 1 | 2000 | 344 | 0.040 |
Why?
|
Vascular Cell Adhesion Molecule-1 | 1 | 2001 | 691 | 0.040 |
Why?
|
Fas Ligand Protein | 1 | 1999 | 215 | 0.040 |
Why?
|
Fibroblasts | 1 | 2008 | 4087 | 0.040 |
Why?
|
Predictive Value of Tests | 1 | 2014 | 15225 | 0.040 |
Why?
|
Longitudinal Studies | 1 | 2014 | 14481 | 0.040 |
Why?
|
Islets of Langerhans Transplantation | 2 | 1993 | 738 | 0.040 |
Why?
|
In Situ Nick-End Labeling | 1 | 1999 | 609 | 0.040 |
Why?
|
Histocytochemistry | 1 | 1999 | 700 | 0.040 |
Why?
|
Milk Proteins | 1 | 1998 | 163 | 0.040 |
Why?
|
Risk Assessment | 1 | 2019 | 23883 | 0.040 |
Why?
|
Antigen-Antibody Complex | 1 | 1999 | 513 | 0.040 |
Why?
|
Humans | 19 | 2014 | 758381 | 0.040 |
Why?
|
Diabetes Mellitus, Type 1 | 1 | 1992 | 3432 | 0.040 |
Why?
|
Gene Rearrangement, T-Lymphocyte | 1 | 1996 | 111 | 0.030 |
Why?
|
Case-Control Studies | 1 | 2014 | 22031 | 0.030 |
Why?
|
Colony-Forming Units Assay | 1 | 1996 | 351 | 0.030 |
Why?
|
Reproducibility of Results | 1 | 2014 | 20052 | 0.030 |
Why?
|
Kidney Function Tests | 1 | 1998 | 677 | 0.030 |
Why?
|
Glomerulonephritis | 1 | 1997 | 337 | 0.030 |
Why?
|
Culture Techniques | 1 | 1996 | 530 | 0.030 |
Why?
|
beta-Galactosidase | 1 | 1996 | 574 | 0.030 |
Why?
|
Receptors, IgG | 1 | 1998 | 559 | 0.030 |
Why?
|
Cell Adhesion | 2 | 1999 | 3090 | 0.030 |
Why?
|
Retroviridae | 1 | 1996 | 850 | 0.030 |
Why?
|
Mice, Inbred NZB | 1 | 1992 | 57 | 0.030 |
Why?
|
Receptor Aggregation | 1 | 1992 | 72 | 0.030 |
Why?
|
Leukocytes, Mononuclear | 1 | 1999 | 1826 | 0.030 |
Why?
|
Hybridomas | 1 | 1993 | 442 | 0.030 |
Why?
|
NF-kappa B | 1 | 2001 | 2472 | 0.030 |
Why?
|
Receptors, Antigen, T-Cell, alpha-beta | 1 | 1996 | 800 | 0.030 |
Why?
|
Models, Immunological | 1 | 1995 | 513 | 0.030 |
Why?
|
CD4-Positive T-Lymphocytes | 2 | 2003 | 4353 | 0.030 |
Why?
|
Safflower Oil | 1 | 1992 | 29 | 0.030 |
Why?
|
Gene Deletion | 1 | 1999 | 2666 | 0.020 |
Why?
|
Tumor Cells, Cultured | 1 | 1999 | 6127 | 0.020 |
Why?
|
Specific Pathogen-Free Organisms | 1 | 1992 | 219 | 0.020 |
Why?
|
Immunoenzyme Techniques | 1 | 1995 | 1705 | 0.020 |
Why?
|
Exotoxins | 1 | 1992 | 121 | 0.020 |
Why?
|
Gene Expression Profiling | 1 | 2007 | 9405 | 0.020 |
Why?
|
Regional Blood Flow | 1 | 1995 | 1486 | 0.020 |
Why?
|
Lymph Nodes | 1 | 2003 | 3485 | 0.020 |
Why?
|
Transplantation, Homologous | 3 | 1995 | 4809 | 0.020 |
Why?
|
Cell Line | 3 | 1995 | 15594 | 0.020 |
Why?
|
Animals, Newborn | 1 | 1996 | 2673 | 0.020 |
Why?
|
Cell Membrane Permeability | 1 | 1992 | 575 | 0.020 |
Why?
|
Oligodeoxyribonucleotides, Antisense | 1 | 2010 | 58 | 0.020 |
Why?
|
Molecular Weight | 1 | 1992 | 2185 | 0.020 |
Why?
|
Nephrectomy | 1 | 1996 | 1016 | 0.020 |
Why?
|
Muscle, Smooth, Vascular | 1 | 1996 | 1486 | 0.020 |
Why?
|
Survival Analysis | 2 | 2000 | 10112 | 0.020 |
Why?
|
Immunologic Memory | 1 | 1996 | 1353 | 0.020 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2003 | 4549 | 0.020 |
Why?
|
Interleukin-23 | 1 | 2010 | 197 | 0.020 |
Why?
|
Tissue Distribution | 1 | 1993 | 2263 | 0.020 |
Why?
|
Lymphoproliferative Disorders | 1 | 1992 | 533 | 0.020 |
Why?
|
Survival Rate | 1 | 2003 | 12721 | 0.020 |
Why?
|
Young Adult | 1 | 2014 | 58808 | 0.020 |
Why?
|
Gene Knockout Techniques | 1 | 2010 | 802 | 0.020 |
Why?
|
Mutation | 1 | 2012 | 29915 | 0.020 |
Why?
|
Ligands | 1 | 1994 | 3258 | 0.020 |
Why?
|
Autoimmunity | 1 | 1995 | 1358 | 0.020 |
Why?
|
Genetic Predisposition to Disease | 1 | 2008 | 17768 | 0.020 |
Why?
|
Diabetes Mellitus, Experimental | 1 | 1993 | 1111 | 0.020 |
Why?
|
Glomerular Filtration Rate | 1 | 1995 | 2154 | 0.020 |
Why?
|
Adolescent | 1 | 2014 | 87888 | 0.020 |
Why?
|
Leukemia P388 | 1 | 1985 | 14 | 0.020 |
Why?
|
Retrospective Studies | 1 | 2014 | 80170 | 0.020 |
Why?
|
Phorbols | 1 | 1985 | 43 | 0.020 |
Why?
|
Leukemia, Experimental | 1 | 1985 | 225 | 0.010 |
Why?
|
Leukemia, Erythroblastic, Acute | 1 | 1985 | 176 | 0.010 |
Why?
|
Eicosapentaenoic Acid | 1 | 1988 | 560 | 0.010 |
Why?
|
Transcription, Genetic | 2 | 2001 | 7590 | 0.010 |
Why?
|
Cell Compartmentation | 1 | 1985 | 384 | 0.010 |
Why?
|
Tetradecanoylphorbol Acetate | 1 | 1985 | 818 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 1999 | 14641 | 0.010 |
Why?
|
Receptors, Antigen, T-Cell | 1 | 1992 | 2532 | 0.010 |
Why?
|
Urea | 1 | 2005 | 444 | 0.010 |
Why?
|
Molecular Sequence Data | 2 | 1993 | 17617 | 0.010 |
Why?
|
Cell Membrane | 1 | 1992 | 3680 | 0.010 |
Why?
|
Immunotherapy, Adoptive | 1 | 1992 | 1454 | 0.010 |
Why?
|
Time Factors | 2 | 1995 | 39873 | 0.010 |
Why?
|
Immunoglobulins | 1 | 2005 | 859 | 0.010 |
Why?
|
Mice, Inbred DBA | 2 | 1993 | 622 | 0.010 |
Why?
|
Caspase 1 | 1 | 2002 | 226 | 0.010 |
Why?
|
Aged | 1 | 2014 | 168217 | 0.010 |
Why?
|
Interleukin-1 | 1 | 1985 | 1249 | 0.010 |
Why?
|
Double-Blind Method | 1 | 1995 | 12262 | 0.010 |
Why?
|
I-kappa B Kinase | 1 | 2001 | 250 | 0.010 |
Why?
|
Middle Aged | 1 | 2014 | 219560 | 0.010 |
Why?
|
Cell Line, Transformed | 1 | 2001 | 869 | 0.010 |
Why?
|
Adult | 1 | 2014 | 219916 | 0.010 |
Why?
|
Green Fluorescent Proteins | 1 | 2005 | 2057 | 0.010 |
Why?
|
Blood Pressure | 1 | 1995 | 8453 | 0.010 |
Why?
|
Aging | 2 | 1996 | 8651 | 0.010 |
Why?
|
STAT5 Transcription Factor | 1 | 1998 | 263 | 0.010 |
Why?
|
Half-Life | 1 | 1998 | 652 | 0.010 |
Why?
|
Models, Biological | 1 | 1993 | 9461 | 0.010 |
Why?
|
Ischemia | 1 | 2005 | 1863 | 0.010 |
Why?
|
Rheumatoid Factor | 1 | 1996 | 185 | 0.010 |
Why?
|
Enzyme Activation | 1 | 2001 | 3593 | 0.010 |
Why?
|
Lymphocyte Subsets | 1 | 1996 | 310 | 0.010 |
Why?
|
Blotting, Western | 1 | 2002 | 5031 | 0.010 |
Why?
|
STAT3 Transcription Factor | 1 | 1998 | 869 | 0.010 |
Why?
|
Tyrosine | 1 | 1998 | 1432 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 1995 | 39060 | 0.010 |
Why?
|
Proinsulin | 1 | 1993 | 135 | 0.010 |
Why?
|
Hematopoietic Stem Cells | 1 | 2005 | 3384 | 0.010 |
Why?
|
T-Lymphocytes, Regulatory | 1 | 1986 | 3071 | 0.010 |
Why?
|
Promoter Regions, Genetic | 1 | 2001 | 5779 | 0.010 |
Why?
|
Protein Precursors | 1 | 1993 | 1133 | 0.000 |
Why?
|
Trans-Activators | 1 | 1998 | 2860 | 0.000 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 1992 | 12076 | 0.000 |
Why?
|
Drug Evaluation, Preclinical | 1 | 1992 | 1335 | 0.000 |
Why?
|
Phosphorylation | 1 | 1998 | 8297 | 0.000 |
Why?
|
Phenylacetates | 1 | 1986 | 112 | 0.000 |
Why?
|
Nitrophenols | 1 | 1986 | 169 | 0.000 |
Why?
|
Leukemia | 1 | 1994 | 1519 | 0.000 |
Why?
|
Pyrogens | 1 | 1985 | 17 | 0.000 |
Why?
|
Phytohemagglutinins | 1 | 1985 | 168 | 0.000 |
Why?
|
Prostaglandins E | 1 | 1985 | 169 | 0.000 |
Why?
|
Lymphoma | 1 | 1994 | 1896 | 0.000 |
Why?
|
Binding, Competitive | 1 | 1985 | 1141 | 0.000 |
Why?
|
Dinoprostone | 1 | 1985 | 598 | 0.000 |
Why?
|
DNA-Binding Proteins | 1 | 1998 | 9575 | 0.000 |
Why?
|
Age Factors | 1 | 1996 | 18357 | 0.000 |
Why?
|
Kinetics | 1 | 1986 | 6371 | 0.000 |
Why?
|
Rabbits | 1 | 1985 | 4771 | 0.000 |
Why?
|
Insulin | 1 | 1993 | 6578 | 0.000 |
Why?
|
Neoplasm Proteins | 1 | 1985 | 3609 | 0.000 |
Why?
|
Antineoplastic Agents | 1 | 1993 | 13591 | 0.000 |
Why?
|